Grifols’ Biotest receives FDA approval for modern Yimmugo ® immunoglobulin to deal with major immunodeficiencies By Investing.com
With Biotest-developed Yimmugo, Grifols provides to its exceptional franchise of intravenous and…
With Biotest-developed Yimmugo, Grifols provides to its exceptional franchise of intravenous and…
